Connection

Co-Authors

This is a "connection" page, showing publications co-authored by MIHAIL CHELU and NA LI.
Connection Strength

2.859
  1. "Sorting" SERCA2a: A novel therapeutic strategy in heart failure? Int J Cardiol. 2018 12 01; 272:306-307.
    View in: PubMed
    Score: 0.646
  2. Biomarkers (plasma trimethylamine-N-oxide) to predict atrial fibrillation: Are we there yet? Int J Cardiol. 2018 09 15; 267:116-117.
    View in: PubMed
    Score: 0.636
  3. Reading Tea Leaves: Epigallocatechin-3-Gallate for Targeting Atrial Fibrosis. Cardiovasc Drugs Ther. 2024 Sep 09.
    View in: PubMed
    Score: 0.246
  4. Cardiac conduction diseases: understanding the molecular mechanisms to uncover targets for future treatments. Expert Opin Ther Targets. 2024 May; 28(5):385-400.
    View in: PubMed
    Score: 0.240
  5. Dapagliflozin for Atrial Fibrillation. Cardiovasc Drugs Ther. 2024 Feb; 38(1):1-3.
    View in: PubMed
    Score: 0.236
  6. Sinus node dysfunction: current understanding and future directions. Am J Physiol Heart Circ Physiol. 2023 03 01; 324(3):H259-H278.
    View in: PubMed
    Score: 0.218
  7. NLRP3 inflammasome is a key driver of obesity-induced atrial arrhythmias. Cardiovasc Res. 2021 06 16; 117(7):1746-1759.
    View in: PubMed
    Score: 0.196
  8. Genetics of atrial fibrillation. Curr Opin Cardiol. 2021 05 01; 36(3):281-287.
    View in: PubMed
    Score: 0.195
  9. Cardiomyocyte Inflammasome Signaling in Cardiomyopathies and Atrial Fibrillation: Mechanisms and Potential Therapeutic Implications. Front Physiol. 2018; 9:1115.
    View in: PubMed
    Score: 0.161
  10. Calmodulin kinase II-mediated sarcoplasmic reticulum Ca2+ leak promotes atrial fibrillation in mice. J Clin Invest. 2009 Jul; 119(7):1940-51.
    View in: PubMed
    Score: 0.086
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.